Home/SEC 13D/G/NVCTSEC 13D/GNVCT - Nuvectis Pharma, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified$NVCT$18.96▲ 123.58% YTDHealthcareAug 6, 2026 · ThinkSabio BlogSEC Filing Update: #NVCT Nuvectis Pharma, Inc. : $18.96 Sector: Healthcare | YTD: 🔼+ 123.58% The SEC disclosed Today (06-AUG-2026) that Soleus Private Equity Fund III, L.P. has Newly bought 150,000 #NVCT shares Ownership: 0.5% * Estimated Investment Value: $3.05M https://www.thinksabio.com/reports/isr/NVCT Institutional ownership in #NVCT has been steadily rising over the past 7 quarters in Shares: Q3 2024: 1.05M Q4 2024: 1.32M Q1 2025: 2.05M Q2 2025: 3.24M Q3 2025: 3.69M Q4 2025: 4.24M Q1 2026: 4.49M The quarterly average prices of #NVCT: Q1 2026: $8.57 Share this post🔗Copy Link💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G